Denali Therapeutics Inc. (DNLI) Operating Lease, Payments USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Denali Therapeutics Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2024.
  • Denali Therapeutics Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $2.79 M, a 6.78% decline year-over-year.
  • Denali Therapeutics Inc. Operating Lease, Payments for the twelve months ending March 31, 2024 was $11.1 M, a 3.67% decline year-over-year.
  • Denali Therapeutics Inc. annual Operating Lease, Payments for 2023 was $11.3 M, a 1.39% increase from 2022.
  • Denali Therapeutics Inc. annual Operating Lease, Payments for 2022 was $11.2 M, a 8.25% increase from 2021.
  • Denali Therapeutics Inc. annual Operating Lease, Payments for 2021 was $10.3 M, a 6.15% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $11.1 M $2.79 M -$203 K -6.78% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $11.3 M $2.79 M -$203 K -6.78% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $11.5 M $2.79 M -$106 K -3.66% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $11.7 M $2.76 M +$87 K +3.25% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $11.6 M $3 M +$378 K +14.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $11.2 M $3 M +$377 K +14.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $10.8 M $2.9 M +$281 K +10.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $10.5 M $2.68 M +$113 K +4.41% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $10.4 M $2.62 M +$82 K +3.23% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $10.3 M $2.62 M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $2.62 M +$82 K +3.23% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.56 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $2.54 M +$336 K +15.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $2.54 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q1 2020 $2.2 M +$1.5 M +214% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q2 2019 $1.9 M Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $700 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.